New Study Alert: Researchers at WiCell confirm that stem cell cultures grow 3.14% better when Pi Day is celebrated by eating pie. Peer review still pending, but we’re happy to repeat the experiment. Happy Pi Day! #PiDay #WiCell #YourLabPartner
关于我们
As a recognized leader in cell line characterization and cell banking, WiCell provides researchers with accurate and reliable characterization testing as well as high-quality hPSC lines for basic and translational research. Characterization service offerings include cGMP compliant karyotype and FISH testing as well as research grade karyotype, FISH, identity by STR, SNP microarray, and mycoplasma testing. WiCell Stem Cell Bank offerings include human ES, iPS, disease models, and engineered cell lines as well as cell lines banked under cGMP conditions. In addition, WiCell offers long-term liquid nitrogen storage and customizable services such as quality control testing and cell banking.
- 网站
-
https://www.wicell.org/?utm_source=linkedin&utm_medium=profileURL&campaign=social_properties
WiCell的外部链接
- 所属行业
- 学术研究
- 规模
- 11-50 人
- 总部
- Madison,WI
- 类型
- 非营利机构
- 创立
- 1999
- 领域
- cell banking、cytogenetic tests、karyotyping、genotyping、identity testing、stem cell characterization、GMP cell banks、hES cells、iPS cells、modified cell lines、disease model cell lines、QC testing和depositing and distributing cell lines
地点
-
主要
504 S Rosa Rd
101
US,WI,Madison,53719
WiCell员工
动态
-
Need a reliable, high-quality karyotype provider? If you are looking for a trusted karyotype provider, partner with WiCell! With decades of experience and a proven track record in cytogenetic testing, we provide the accuracy and expertise researchers rely on. Why choose WiCell? ? Reliable expertise – Trusted by researchers, biotech companies, and academic labs. ? Dedicated support – Personalized services to meet your unique requirements. ? cGMP-compliant – Karyotyping for clinical-grade applications available. Let’s talk about how we can support your research. Find out more: https://hubs.la/Q039Lgy60 #Karyotype #Cytogenetics #StemCellResearch #WiCell #YourLabPartner
-
-
Did you know today is Rare Disease Day? This day brings attention to the millions affected by rare diseases and highlights the ongoing efforts to improve lives through research. At WiCell, we are honored to collaborate with researchers worldwide, providing stem cell resources that help advance our understanding of rare diseases and pave the way for new treatments. Visit https://hubs.la/Q037Qd570 to learn more about Rare Disease Day and discover how you can get involved. #RareDiseaseDay #RareDiseases #StemCellResearch #YourLabPartner
-
-
Protect your samples with WiCellSAFE. Our service provides 24/7 monitoring of storage conditions, including tank temperature and other critical factors, to ensure your biological materials remain safely preserved. Whether you're protecting your work from accidental loss or need to pause your research, we’ve got you covered. Store your samples safely and affordably. For more details, check here: https://hubs.la/Q036FVSY0
-
-
WiCell转发了
The ISSCR Standards Task Force is meeting in Edinburgh, UK to discuss and update the Best Practices for PSC-Based Therapies document, based on feedback from external peer review. Stay tuned to see what updates come out of this meeting! Learn more??https://bit.ly/4aZ8wbu Jack T Mosher | Chris Barry | Kapil Bharti | Jacqueline Barry | Ricardo Baptista | Melissa Carpenter | Derek Hei | Deborah Hursh | Ana Hidalgo-Simon | Tenneille Ludwig | Hideyuki Okano | John Rasko AO | Yoji Sato | Clive Svendsen
-
-
WiCell is looking for a dedicated QA Specialist to join our team. This role offers the opportunity to play a key role in quality assurance while supporting meaningful scientific research. We are seeking a detail-oriented professional who is committed to excellence and thrives in a collaborative environment! WiCell is committed to providing a supportive and inclusive workplace where employees can grow and succeed. We offer competitive benefits, a strong work-life balance, and a team-driven culture that values collaboration and innovation. Learn more and apply here: https://hubs.la/Q036cJyb0.
-
-
WiCell is seeking a dedicated and detail-oriented QA Specialist to join our team! This role provides the opportunity to play a key part in quality assurance activities while contributing to impactful scientific research. If you’re passionate about maintaining high standards and thrive in a dynamic, collaborative environment, we’d love to hear from you. To learn more about the role and apply, visit: https://hubs.la/Q034t_Sz0
-
-
The gold standard for assessing genomic stability in cell lines is G-banded karyotype. With decades of experience and the ability to perform cGMP-compliant testing, we serve both research and clinical needs with precision and reliability. WiCell's services include: -Expert cytogenetic analysis backed by years of experience -cGMP-compliant karyotyping for clinical-grade applications -Turnaround times of 7–10 days without compromising quality -Support tailored to fit the unique requirements of your project We are dedicated to ensuring the integrity of your cell lines and advancing your research goals. Explore how our karyotyping services can support your work: https://hubs.la/Q033KQr10 If you missed it, check out our blog about the importance of G-banded karyotyping in ensuring the quality of your research: https://hubs.la/Q033KpTN0 #WiCell #YourLabPartner #Karyotyping #Cytogenetics #cGMPCompliance #CellResearch
-
-
More exciting news from our friends at BlueRock Therapeutics and Bayer! Congratulations on this promising work.
Together with Bayer, we have announced plans to initiate a Phase III clinical trial for bemdaneprocel, our investigational cell therapy for Parkinson’s disease. The registrational trial, named exPDite-2, is expected to begin in the first half of 2025 and will represent a significant milestone in the development of allogeneic cell-based therapies for neurodegenerative disorders. Learn more: https://lnkd.in/ebaR_zf9
-
-
It's that time of year again—time for the WiCell Year End Blog! This year we are reflecting on 25 years of collaboration and growth. Our year end blog highlights key moments from 2024, including expanded stem cell characterization services and the completion of a dedicated GMP space to meet growing research needs. With a look ahead to 2025, we share how these efforts continue to support researchers and drive progress in regenerative medicine. Read the full blog to explore the milestones and how we can advance science together with you, our partners, for the next 25 years. https://hubs.la/Q030KDJQ0
-